No Image Available

Ferric Derisomaltose Generics

Form: IV Infusion

Strength: 200 mg/ml

Reference Brands: Monoferric® (U.S.) and Monofer® (EU))

Category: Anemia

Ferric Derisomaltose, marketed as Monoferric® in the U.S. and Monofer® in the EU, is a next-generation intravenous iron therapy used for treating iron deficiency anemia in adults, particularly when oral iron is ineffective or not tolerated. Its high-concentration formulation (200 mg/mL) allows for single high-dose administration, improving patient compliance and reducing treatment time. In the pharmaceutical B2B market, Ferric Derisomaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In both the U.S. and EU, it is supplied under GMP conditions for institutional supply, private labeling, and international distribution through licensed manufacturers and contract partners

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Deferoxamine

Strength: 500 mg/vial, 2 g/vial

Form: Lyophilized powder for injection

Reference Brands: Desferal

View Details Get Enquiry
Deferasirox

Strength: 125 mg, 250 mg, 500 mg

Form: Tablets for Oral Suspension

Reference Brands: Exjade, Jadenu (film-coated)

View Details Get Enquiry
Iron(III)-Isomaltoside Injection

Strength: 100mg/ml

Form: Injection

Reference Brands: Monofer,, Diafer, Monoferric

View Details Get Enquiry
Iron Dextran

Strength: 50 mg/mL

Form: injection

Reference Brands: Dexferrum,INFeD

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.